MAZOR ROBOTICS LTD. | CIK:0001566844 | 3

  • Filed: 4/30/2018
  • Entity registrant name: MAZOR ROBOTICS LTD. (CIK: 0001566844)
  • Generator: GoXBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1566844/000117891318001361/0001178913-18-001361-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1566844/000117891318001361/mzor-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001566844
  • Open this page in separate window: Click
  • ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory

    G.
    Impairment

    (1)
    Non-derivative financial assets

    A financial asset not carried at fair value through profit or loss is tested for impairment when objective evidence indicates that one or more events had a negative effect on the estimated future cash flows of the asset.

    Objective evidence that financial assets are impaired may include:
     
    default by a debtor;
    indications that a debtor or issuer will enter bankruptcy; or
    observable data indicating a measurable decrease in the cash flow expected from a group of financial assets.

    An impairment loss in respect of a financial asset measured at amortized cost is calculated as the difference between its carrying amount and the present value of the estimated future cash flows discounted at the asset’s original effective interest rate. All individually significant financial assets are assessed for specific impairment, and all impairment losses are recognized in profit or loss and reflected in a provision for loss against the balance of the financial asset measured at amortized cost.

    An impairment loss is reversed if the reversal can be related objectively to an event occurring after the recognition of the impairment loss. For financial assets measured at amortized cost the reversal is recognized in profit or loss.
     
     (2)
    Non-financial assets
     
    The carrying amounts of the Group’s non-financial assets, other than inventories and deferred tax assets, are reviewed at each reporting date to determine whether there is any indication of impairment. If any such indication exists, then the asset’s recoverable amount is estimated.

    The recoverable amount of an asset or cash-generating unit is the greater of its value in use and its net selling price (fair value less costs to sell the asset). In assessing value in use, the estimated future cash flows are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset or cash-generating unit, for which the estimated future cash flows from the asset or cash-generating unit were not adjusted. For the purpose of impairment testing, assets are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.

    An impairment loss is recognized if the carrying amount of an asset or its cash-generating unit exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of cash-generating units are allocated to reduce the carrying amounts of each of the assets in the cash-generating unit on a pro rata basis.
     
    Impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized initially.